A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body
Clinical trial NCT06494761 · COMPLETED
Trial details
- NCT number
- NCT06494761
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2024-10-16
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.